Concise review: Patient-derived olfactory stem cells: New models for brain diseases

Stem Cells

Volumn 30, Issue 11, 2012, Pages 2361-2365

  Mackay Sim, Alan ^a  

^a GRIFFITH UNIVERSITY   (Australia)

Author keywords

Clinical translation; Disease model; Drug target; Familial dysautonomia; Nervous system; Neural stem cell; Parkinson's disease; Schizophrenia

Indexed keywords

BRAIN DISEASE; DYSAUTONOMIA; GENE EXPRESSION; GENETIC VARIABILITY; HUMAN; MUCOSA CELL; OLFACTORY STEM CELL; OLFACTORY SYSTEM; OXIDATIVE STRESS; PARKINSON DISEASE; REVIEW; SCHIZOPHRENIA; STEM CELL;

ADULT STEM CELLS; ANIMALS; BRAIN DISEASES; CELL CYCLE; CELLS, CULTURED; DRUG EVALUATION, PRECLINICAL; GENE EXPRESSION REGULATION; HUMANS; NEURAL STEM CELLS; OLFACTORY MUCOSA; OXIDATIVE STRESS;

EID: 84867916434     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.1220     Document Type: Review

References (62)

1. Schnabel J. Neuroscience: Standard model. Nature 2008;454:682-685.
2. Wray NR, Goddard ME, Visscher PM. Prediction of individual genetic risk of complex disease. Curr Opin Genet Dev 2008;18:257-263.
3. Sutherland GT, Matigian NA, Chalk AM et al. A cross-study transcriptional analysis of Parkinson's disease. PLoS One 2009;4:e4955.
4. Atz M, Walsh D, Cartagena P et al. Methodological considerations for gene expression profiling of human brain. J Neurosci Methods 2007;163:295-309. (Pubitemid 46874608)
5. Marcotte ER, Srivastava LK, Quirion R. cDNA microarray and proteomic approaches in the study of brain diseases: Focus on schizophrenia and Alzheimer's disease. Pharmacol Ther 2003;100:63-74. (Pubitemid 37204900)
6. Preece P, Cairns NJ. Quantifying mRNA in postmortem human brain: Influence of gender, age at death, postmortem interval, brain pH, agonal state and inter-lobe mRNA variance. Brain Res Mol Brain Res 2003;118:60-71. (Pubitemid 37238988)
7. Abramov AY, Gegg M, Grunewald A et al. Bioenergetic consequences of PINK1 mutations in Parkinson disease. PLoS One 2011;6:e25622.
8. Kobayashi H, Kruger R, Markopoulou K et al. Haploinsufficiency at the alpha-synuclein gene underlies phenotypic severity in familial Parkinson's disease. Brain 2003;126:32-42. (Pubitemid 36068558)
9. Matigian NA, McCurdy RD, Feron F et al. Fibroblast and lymphoblast gene expression profiles in schizophrenia: Are non-neural cells informative? PLoS One 2008;3:e2412.
10. Morikawa T, Manabe T, Ito Y et al. The expression of HMGA1a is increased in lymphoblastoid cell lines from schizophrenia patients. Neurochem Int 2010;56:736-739.
11. Wang L, Lockstone HE, Guest PC et al. Expression profiling of fibroblasts identifies cell cycle abnormalities in schizophrenia. J Proteome Res 2010;9:521-527.
12. Grskovic M, Javaherian A, Strulovici B et al. Induced pluripotent stem cells - Opportunities for disease modelling and drug discovery. Nat Rev Drug Discov 2011;10:915-929.
13. Doty RL. The olfactory system and its disorders. Semin Neurol 2009;29:74-81.
14. Mackay-Sim A, Johnston AN, Owen C et al. Olfactory ability in the healthy population: Reassessing presbyosmia. Chem Senses 2006;31:763-771. (Pubitemid 44530680)
15. Arnold SE, Han LY, Moberg PJ et al. Dysregulation of olfactory receptor neuron lineage in schizophrenia. Arch Gen Psychiatry 2001;58:829-835. (Pubitemid 32979300)
16. Duda JE, Shah U, Arnold SE et al. The expression of alpha-, beta-, and gamma-synucleins in olfactory mucosa from patients with and without neurodegenerative diseases. Exp Neurol 1999;160:515-522.
17. Ronnett GV, Leopold D, Cai X et al. Olfactory biopsies demonstrate a defect in neuronal development in Rett's syndrome. Ann Neurol 2003;54:206-218. (Pubitemid 36909619)
18. Graziadei GA, Graziadei PP. Neurogenesis and neuron regeneration in the olfactory system of mammals. II. Degeneration and reconstitution of the olfactory sensory neurons after axotomy. J Neurocytol 1979;8:197-213. (Pubitemid 9175213)
19. Graziadei PP. Cell dynamics in the olfactory mucosa. Tissue Cell 1973;5:113-131.
20. Murrell W, Bushell GR, Livesey J et al. Neurogenesis in adult human. Neuroreport 1996;7:1189-1194. (Pubitemid 26227037)
21. Chen X, Fang H, Schwob JE. Multipotency of purified, transplanted globose basal cells in olfactory epithelium. J Comp Neurol 2004;469:457-474. (Pubitemid 38140648)
22. Leung CT, Coulombe PA, Reed RR. Contribution of olfactory neural stem cells to tissue maintenance and regeneration. Nat Neurosci 2007;10:720-726. (Pubitemid 46828492)
23. Mackay-Sim A, Kittel P. Cell dynamics in the adult mouse olfactory epithelium: A quantitative autoradiographic study. J Neurosci 1991;11:979-984.
24. Delorme B, Nivet E, Gaillard J et al. The human nose harbors a niche of olfactory ectomesenchymal stem cells displaying neurogenic and osteogenic properties. Stem Cells Dev 2010;19:853-866.
25. Matigian N, Abrahamsen G, Sutharsan R et al. Disease-specific, neurosphere-derived cells as models for brain disorders. Dis Model Mech 2010;3:785-798.
26. Tome M, Lindsay SL, Riddell JS et al. Identification of nonepithelial multipotent cells in the embryonic olfactory mucosa. Stem Cells 2009;27:2196-2208.
27. Feron F, Perry C, McGrath JJ et al. New techniques for biopsy and culture of human olfactory epithelial neurons. Arch Otolaryngol Head Neck Surg 1998;124:861-866. (Pubitemid 28369203)
28. Wolozin B, Sunderland T, Zheng BB et al. Continuous culture of neuronal cells from adult human olfactory epithelium. J Mol Neurosci 1992;3:137-146.
29. Newman MP, Feron F, Mackay-Sim A. Growth factor regulation of neurogenesis in adult olfactory epithelium. Neuroscience 2000;99:343-350. (Pubitemid 30628422)
30. Murrell W, Feron F, Wetzig A et al. Multipotent stem cells from adult olfactory mucosa. Dev Dyn 2005;233:496-515. (Pubitemid 40734050)
31. Roisen FJ, Klueber KM, Lu CL et al. Adult human olfactory stem cells. Brain Res 2001;890:11-22. (Pubitemid 32119523)
32. Murrell W, Sanford E, Anderberg L et al. Olfactory stem cells can be induced to express chondrogenic phenotype in a rat intervertebral disc injury model. Spine J 2009;9:585-594.
33. Murrell W, Wetzig A, Donnellan M et al. Olfactory mucosa is a potential source for autologous stem cell therapy for Parkinson's disease. Stem Cells 2008;26:2183-2192.
34. Wolozin B, Lesch P, Lebovics R et al. A. E. Bennett Research Award 1993. Olfactory neuroblasts from Alzheimer donors: Studies on App processing and cell regulation. Biol Psychiatry 1993;34:824-838. (Pubitemid 24021228)
35. Johnson GS, Basaric-Keys J, Ghanbari HA et al. Protein alterations in olfactory neuroblasts from Alzheimer donors. Neurobiol Aging 1994;15:675-680. (Pubitemid 24360157)
36. Ghanbari HA, Ghanbari K, Harris PL et al. Oxidative damage in cultured human olfactory neurons from Alzheimer's disease patients. Aging Cell 2004;3:41-44. (Pubitemid 40246661)
37. Abrams MT, Kaufmann WE, Rousseau F et al. FMR1 gene expression in olfactory neuroblasts from two males with fragile X syndrome. Am J Med Genet 1999;82:25-30. (Pubitemid 29022294)
38. Feron F, Perry C, Hirning MH et al. Altered adhesion, proliferation and death in neural cultures from adults with schizophrenia. Schizophr Res 1999;40:211-218.
39. McCurdy RD, Feron F, Perry C et al. Cell cycle alterations in biopsied olfactory neuroepithelium in schizophrenia and bipolar I disorder using cell culture and gene expression analyses. Schizophr Res 2006;82:163-173. (Pubitemid 43290680)
40. Rietze RL, Reynolds BA. Neural stem cell isolation and characterization. Methods Enzymol 2006;419:3-23. (Pubitemid 44820360)
41. Raedler TJ, Knable MB, Weinberger DR. Schizophrenia as a developmental disorder of the cerebral cortex. Curr Opin Neurobiol 1998;8:157-161. (Pubitemid 28151870)
42. Lesage S, Brice A. Parkinson's disease: From monogenic forms to genetic susceptibility factors. Hum Mol Genet 2009;18:R48-59.
43. Harrison PJ. Schizophrenia: A disorder of neurodevelopment? Curr Opin Neurobiol 1997;7:285-289. (Pubitemid 27219866)
44. Henchcliffe C, Beal MF. Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis. Nat Clin Pract Neurol 2008;4:600-609.
45. Fan Y, Abrahamsen G, McGrath JJ et al. Altered cell cycle dynamics in schizophrenia. Biol Psychiatry 2012;71:129-135.
46. Barone MC, Sykiotis GP, Bohmann D. Genetic activation of Nrf2 signaling is sufficient to ameliorate neurodegenerative phenotypes in a Drosophila model of Parkinson's disease. Dis Model Mech 2011;4:701-707.
47. Cook AL, Vitale AM, Ravishankar S et al. NRF2 activation restores disease related metabolic deficiencies in olfactory neurosphere-derived cells from patients with sporadic Parkinson's disease. PLoS One 2011;6:e21907.
48. Waddington CH. Canalization of development and genetic assimilation of acquired characters. Nature 1959;183:1654-1655.
49. Mar JC, Matigian NA, Mackay-Sim A et al. Variance of gene expression identifies altered network constraints in neurological disease. PLoS Genet 2011;7:e1002207.
50. Boone N, Loriod B, Bergon A et al. Olfactory stem cells, a new cellular model for studying molecular mechanisms underlying familial dysautonomia. PLoS One 2010;5:e15590.
51. Boone N, Bergon A, Loriod B et al. Genome-wide analysis of familial dysautonomia and kinetin target genes with patient olfactory ecto-mesenchymal stem cells. Hum Mutat 2012;33:530-540.
52. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126:663-676. (Pubitemid 44233629)
53. Dimos JT, Rodolfa KT, Niakan KK et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 2008;321:1218-1221.
54. Park IH, Arora N, Huo H et al. Disease-specific induced pluripotent stem cells. Cell 2008;134:877-886.
55. Ebert AD, Yu J, Rose FF, Jr. et al. Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 2009;457:277-280.
56. Lee G, Papapetrou EP, Kim H et al. Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs. Nature 2009;461:402-406.
57. Nguyen HN, Byers B, Cord B et al. LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress. Cell Stem Cell 2011;8:267-280.
58. Soldner F, Hockemeyer D, Beard C et al. Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 2009;136:964-977.
59. Brennand KJ, Simone A, Jou J et al. Modelling schizophrenia using human induced pluripotent stem cells. Nature 2011;473:221-225.
60. Chiang CH, Su Y, Wen Z et al. Integration-free induced pluripotent stem cells derived from schizophrenia patients with a DISC1 mutation. Mol Psychiatry 2011;16:358-360.
61. Saha K, Jaenisch R. Technical challenges in using human induced pluripotent stem cells to model disease. Cell Stem Cell 2009;5:584-595.
62. Vierbuchen T, Ostermeier A, Pang ZP et al. Direct conversion of fibroblasts to functional neurons by defined factors. Nature 2010;463:1035-1041.